Fol. Biol. 2011, 57, 139-144

https://doi.org/10.14712/fb2011057040139

RhoA Distribution in Renal Caveolar Fractions in Experimental Type 1 Diabetes

Hana Demová, M. Černá

Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic Institute of General Biology and Genetics, Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic

Received March 2011
Accepted April 2011

Caveolae act as signalling platforms serving as concentrating points for numerous signalling molecules, as well as regulating flux through many distinct signalling cascades. RhoA proteins have been identified as potential actors in the pathophysiology of the cardiovascular system. We used sucrose gradient fractionation and immunoblotting to determine caveolin-1 and RhoA presence in the kidney cortex of streptozotocin-induced T1 diabetes rats (4-week duration), and of diabetic rats treated with angiotensin receptor blocker losartan (4 weeks, 20 mg/kg/day) to retard renal hypertension. Positive RhoA/caveolin-1 co-immunoprecipitation result was detected in the caveolar fraction that corresponded to the light-scattering band obtained from diabetic rats, compared to negative co-immunoprecipitation result in the caveolar fraction obtained from control rats. The detection of RhoA protein in the caveolar fractions and the prospective RhoA/caveolin-1 association can be used to examine the role of these signalling reactions in the pathophysiology of microvascular complications in type 1 diabetes.

Funding

This study was financially supported by the EU grant FP6-2004-LIFESCIHEALTH-5: 018733: The Identification of Risk Factors for the Development of Diabetic Nephropathy and by the Research design of the Ministry of Education and Youth of Czech Republic: Identification code: MSM 0021620814: Prevention, diagnostics and therapy of diabetes mellitus, metabolic and endocrine damage of organism.

References

33 live references